Beyond CNVs: Leveraging SNP Arrays in Cancer

Explore the potential of SNP arrays in cancer genomics beyond copy number variations (CNVs) in this 21-minute conference talk from the 2022 Cancer Genomics Consortium Annual Meeting. Delve into Oxford Gene Technology's presentation, which covers topics such as mosaic gains and losses, ovarian cancer, HRD scores, and noninformative SNPs. Learn about the challenges faced by those unable to perform next-generation sequencing and discover alternative approaches. Gain insights into the application of SNP arrays in detecting various genomic alterations and their implications for cancer diagnosis and treatment. Understand the importance of accurate genomic testing in providing appropriate therapy for cancer patients.